EP0759750A4 - Compositions for treatment of chronic inflammatory diseases - Google Patents

Compositions for treatment of chronic inflammatory diseases

Info

Publication number
EP0759750A4
EP0759750A4 EP95921256A EP95921256A EP0759750A4 EP 0759750 A4 EP0759750 A4 EP 0759750A4 EP 95921256 A EP95921256 A EP 95921256A EP 95921256 A EP95921256 A EP 95921256A EP 0759750 A4 EP0759750 A4 EP 0759750A4
Authority
EP
European Patent Office
Prior art keywords
compositions
treatment
inflammatory diseases
chronic inflammatory
chronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP95921256A
Other languages
German (de)
French (fr)
Other versions
EP0759750A1 (en
Inventor
Howard K Shapiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0759750A1 publication Critical patent/EP0759750A1/en
Publication of EP0759750A4 publication Critical patent/EP0759750A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
EP95921256A 1994-05-11 1995-05-11 Compositions for treatment of chronic inflammatory diseases Ceased EP0759750A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24160394A 1994-05-11 1994-05-11
US241603 1994-05-11
PCT/US1995/006044 WO1995031194A1 (en) 1994-05-11 1995-05-11 Compositions for treatment of chronic inflammatory diseases

Publications (2)

Publication Number Publication Date
EP0759750A1 EP0759750A1 (en) 1997-03-05
EP0759750A4 true EP0759750A4 (en) 1998-05-27

Family

ID=22911379

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95921256A Ceased EP0759750A4 (en) 1994-05-11 1995-05-11 Compositions for treatment of chronic inflammatory diseases

Country Status (4)

Country Link
EP (1) EP0759750A4 (en)
AU (1) AU698881B2 (en)
CA (1) CA2190107A1 (en)
WO (1) WO1995031194A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103748A (en) * 1998-06-19 2000-08-15 Bryan; Thomas B. Method of treating an autoimmune disorder
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
CA2420576C (en) * 2000-08-29 2005-06-14 Nobex Corporation Immunoregulatory compounds, derivatives thereof and their use
JP2005530772A (en) * 2002-05-09 2005-10-13 ミモトープス・プロプライエタリー・リミテッド Amino acid analogs
GB0218590D0 (en) * 2002-08-09 2002-09-18 Pfizer Ltd Therapeutic use of aryl amino acid derivatives
US7053122B2 (en) 2002-08-09 2006-05-30 Pfizer Inc Therapeutic use of aryl amino acid derivatives
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
IL157397A (en) 2003-08-14 2013-03-24 Dpharm Ltd Compounds, pharmaceutical compositions comprising same and uses thereof for the preparation of a medicament for the treatment of epilepsy
CA2553775A1 (en) * 2004-01-20 2005-08-11 Richard F. Harty Compositions and methods of treatment for inflammatory diseases
HUE039705T2 (en) * 2004-03-23 2019-02-28 Biocon Ltd Methods and compositions employing 4-aminophenylacetic acid compounds
DE102005001113A1 (en) * 2005-01-08 2006-07-20 Regeneratio Pharma Gmbh Use of metal complexes of tetrapyrrole heterocycles for the treatment of inflammatory stomach / intestinal diseases
ITRM20050390A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
ITRM20050389A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
US8614236B2 (en) 2006-12-12 2013-12-24 University Of Washington Methods of treating pulmonary disease using acetazolamide and structurally related derivatives
CA2937492C (en) 2008-11-11 2019-08-13 The Board Of Regents Of The University Of Texas System Inhibition of mammalian target of rapamycin
UA107562C2 (en) * 2008-12-05 2015-01-26 METHOD OF TREATMENT OF PSORIASIS
PT2396081T (en) 2009-02-16 2017-07-11 Nogra Pharma Ltd Alkylamido compounds and uses thereof
US9283211B1 (en) 2009-11-11 2016-03-15 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
CA2864059C (en) 2012-02-09 2020-04-28 Nogra Pharma Limited Methods of treating fibrosis
BR112014026160A2 (en) 2012-04-18 2017-07-18 Nogra Pharma Ltd Methods To Treat Lactose Intolerance
WO2014160328A1 (en) 2013-03-13 2014-10-02 The Board Of Regents Of The University Of Texas System Mtor inhibitors for prevention of intestinal polyp growth
ES2900426T3 (en) 2013-12-31 2022-03-16 Rapamycin Holdings Llc Oral preparations and use of rapamycin nanoparticles
US9700544B2 (en) 2013-12-31 2017-07-11 Neal K Vail Oral rapamycin nanoparticle preparations
EP3589369A4 (en) 2017-01-09 2020-03-18 DAS-MG, Inc. Use and composition for treating myasthenia gravis and other myasthenic syndromes
WO2018136266A1 (en) * 2017-01-18 2018-07-26 Chien Du Shieng Compositions for use in treating inflammatory bowel diseases and intestinal colitis
US20200000756A1 (en) * 2017-01-24 2020-01-02 Gt Biopharma, Inc. Neostigmine combination and compositions
RU2711624C2 (en) * 2017-06-30 2020-01-17 Общество с ограниченной ответственностью "ФБК" Combined agent based on nsiad, muscle relaxant and vitamin
EA202192207A1 (en) 2019-02-08 2021-10-27 Ногра Фарма Лимитед METHOD FOR OBTAINING 3- (4'-AMINOPHENYL) -2-METHOXYPROPIONIC ACID AND ITS ANALOGUES AND INTERMEDIATE COMPOUNDS

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117910A (en) * 1961-11-15 1964-01-14 Osterweil Jacob Medicinal compositions
FR6409M (en) * 1966-12-07 1968-10-28
US4272512A (en) * 1980-01-31 1981-06-09 Colgate-Palmolive Company Antigingivitis composition
EP0094599A1 (en) * 1982-05-11 1983-11-23 Mitsubishi Kasei Corporation Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation
DE3800968A1 (en) * 1988-01-15 1989-07-27 Asche Karl W Substance in powder form as pharmaceutical
JPH02200622A (en) * 1989-01-28 1990-08-08 Sansho Seiyaku Co Ltd External agent for suppressing melanogenesis
US4959205A (en) * 1989-03-23 1990-09-25 Collagen Corporation Composition and method for treatment of dermal inflammation
WO1994000135A1 (en) * 1992-06-30 1994-01-06 Shapiro Howard K Composition containing amine and amine-related derivatives of benzoic acid and uses therefor including treating inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956504A (en) * 1972-06-02 1976-05-11 Philip Nicholas Sawyer Method of preventing thromboses

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117910A (en) * 1961-11-15 1964-01-14 Osterweil Jacob Medicinal compositions
FR6409M (en) * 1966-12-07 1968-10-28
US4272512A (en) * 1980-01-31 1981-06-09 Colgate-Palmolive Company Antigingivitis composition
EP0094599A1 (en) * 1982-05-11 1983-11-23 Mitsubishi Kasei Corporation Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation
DE3800968A1 (en) * 1988-01-15 1989-07-27 Asche Karl W Substance in powder form as pharmaceutical
JPH02200622A (en) * 1989-01-28 1990-08-08 Sansho Seiyaku Co Ltd External agent for suppressing melanogenesis
US4959205A (en) * 1989-03-23 1990-09-25 Collagen Corporation Composition and method for treatment of dermal inflammation
WO1994000135A1 (en) * 1992-06-30 1994-01-06 Shapiro Howard K Composition containing amine and amine-related derivatives of benzoic acid and uses therefor including treating inflammatory diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 14, no. 485 (C - 772) 23 October 1990 (1990-10-23) *
See also references of WO9531194A1 *

Also Published As

Publication number Publication date
WO1995031194A1 (en) 1995-11-23
EP0759750A1 (en) 1997-03-05
AU2637895A (en) 1995-12-05
CA2190107A1 (en) 1995-11-23
AU698881B2 (en) 1998-11-12

Similar Documents

Publication Publication Date Title
EP0759750A4 (en) Compositions for treatment of chronic inflammatory diseases
IL121170A0 (en) Compositions for the treatment of dermatological disorders
IL142908A0 (en) Compounds useful in the treatment of inflammatory diseases
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
HK1042475A1 (en) Substituted thiazoles for the treatment of inflammation
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
FI953180A0 (en) Compositions for the treatment of diabetic complications
HU9402817D0 (en) Compounds for treating allergic and inflammatory diseases
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
IL138129A (en) Composition for therapy of estrogen-associated disorders
EP0942742A4 (en) Therapeutic compositions for treatment of cancer
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
PL314996A1 (en) Kappa-opiatagonistic agents for treating intestinal inflammatory diseases
EP0777474A4 (en) Methods for the treatment of inflammatory joint disease
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
EP0938901A4 (en) Medicinal compositions for treating liver diseases
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
IL119459A0 (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
HUP0003679A3 (en) Use of pkc inhibitors for the preparation of pharmaceutical compositions treating cardiovascular diseases
IL121217A0 (en) Pharmaceutical composition for treating chronic progressive vascular diseases
IL119225A (en) Pharmaceutical compositions for the treatment of asthma in mammals
IL113057A0 (en) Compositions for the treatment of dandruff
GB9510162D0 (en) Compositions for the treatment of skin conditions
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
EP0755262A4 (en) Composition for the treatment of lung disease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961211

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19980415

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020313

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20040207